Oral lead removal trial for kidney health in type 2 diabetes
Part of Hormones & metabolism, Kidney & urinary clinical trials.
This trial tests if taking an oral medication to remove lead from the body can slow down kidney function loss in people with type 2 diabetes and kidney disease. It may help if you have higher lead levels in your blood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes with kidney disease.
- Your blood lead level is 5 micrograms per deciliter or higher.
- Your chronic kidney disease is stage 3 or earlier (moderate or less).
- Your 24-hour urine protein is less than 8 grams.
- You are 18 years of age or older.
- You can sign a consent form and attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medicine given through a vein (IV) that binds to lead in your blood can help slow kidney damage in people with type 2 diabetes who also have higher-than-normal lead levels.
This Phase 2 study tests whether adding NAD can improve kidney health in people with diabetes-related kidney disease. It is designed for people with certain urine lab results showing kidney stress, while keeping blood sugar and safety limits within range.
This trial tests if an oral medication that absorbs toxins plus probiotics can reduce inflammation and slow kidney damage in people with diabetes-related kidney disease (DKD). It may help those with mild to severe kidney function loss.
This trial focuses on improving how kidney damage is diagnosed and how treatment is planned for people with type 2 diabetes and kidney disease. It may help by using detailed medical history and (if done) kidney biopsy results to guide care more accurately.
This trial tests whether a deep dental cleaning procedure can help slow the progression of advanced kidney disease in people with type 2 diabetes who are not yet on dialysis. It may be an option for those with moderate gum disease and at least 20 natural teeth.
This trial tests a new system to manage diabetic kidney disease across all stages. It is for people with type 2 diabetes who either have no kidney damage or have kidney damage confirmed by a biopsy.
Hear when a new Type 2 Diabetic Nephropathy With Elevated Blood Lead Burden trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.